SCHEMBL9566522

SCHEMBL9566522

Nc1nc(N)nc(-c2cc(F)ccc2Cl)n1

nearest known ligand 0.68

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 1/20 0.68
PDE4D Q08499 1/20 0.68
NPC1 O15118 6/20 0.64
RAB9A P51151 2/20 0.50
HSP90AA1 P07900 3/20 0.41
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
AGPAT2 O15120 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
HSP90AB1 P08238 2/20 0.39
ABL1 P00519 1/20 0.38
ADORA2A P29274 1/20 0.38
HRH4 Q9H3N8 1/20 0.37
DPP4 P27487 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Irsogladine SCHEMBL29517870 0.81 HTR2B (1.00) HTR2BPDE4DNPC1RAB9AHSP90AA1
Irsogladine SCHEMBL62215 0.81 HTR2B (1.00) HTR2BPDE4DNPC1RAB9AHSP90AA1
SCHEMBL9566537 0.81 NPC1 (0.68) HTR2BPDE4DNPC1RAB9AMEN1
SCHEMBL9566542 0.81 HTR2B (0.72) HTR2BPDE4DNPC1RAB9AHSP90AA1
SCHEMBL9566562 0.78 HTR2B (0.68) HTR2BPDE4DNPC1RAB9AHSP90AA1
SCHEMBL9566593 0.78 HTR2B (0.68) HTR2BPDE4DNPC1RAB9AHSP90AA1
SCHEMBL17866357 0.78 NPC1 (1.00) HTR2BPDE4DNPC1RAB9AHSP90AA1
SCHEMBL9566543 0.78 NPC1 (0.64) HTR2BPDE4DNPC1RAB9AMEN1
SCHEMBL9566466 0.78 HTR2B (0.68) HTR2BPDE4DNPC1RAB9AHSP90AA1
SCHEMBL11612298 0.77 HTR2B (0.62) HTR2BPDE4DNPC1RAB9AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0563386-A1 ANTICANCER COMPOSITION AND COMPOUND NIPPON SHINYAKU COMPANY, LIMITED (JP) 1993-10-06 EP disclosed